Skip to main content
VCbacked
Log inGet Started

Innovo Therapeutics

San Diego, United States

Innovo Therapeutics is a anti-cancer drug developer committed to research and creation of medications that target protein breakdown.

$14.1M raised
Dec 2023
Seed
BiotechnologyMedicalProduct Research

Top Investors

CICCHuajin CapitalMing BioventuresLongmen CapitalHMC Ventures

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Innovo Therapeutics

How much funding has Innovo Therapeutics raised?
Innovo Therapeutics has raised $14.1M in total funding. The most recent round was Seed. The last funding was announced in December 2023.
Who are Innovo Therapeutics's investors?
Innovo Therapeutics's investors include CICC, Huajin Capital, Ming Bioventures, Longmen Capital, HMC Ventures.
Where is Innovo Therapeutics headquartered?
Innovo Therapeutics is headquartered in San Diego, United States.
What does Innovo Therapeutics do?
Innovo Therapeutics is a anti-cancer drug developer committed to research and creation of medications that target protein breakdown.
What stage is Innovo Therapeutics at?
Innovo Therapeutics is at the Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Innovo Therapeutics — Funding & Investors." VCBacked, December 1, 2023, https://www.vcbacked.co/company/innovo-therapeutics. Accessed June 17, 2026.
APA
VCBacked. (2023). Innovo Therapeutics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/innovo-therapeutics
Wikipedia (cite web)
{{cite web |title=Innovo Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/innovo-therapeutics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong